To: jgercke who wrote (2329 ) 5/20/1998 11:51:00 AM From: The Philosopher Read Replies (1) | Respond to of 5944
Thanks for the post. I agree that it's not all that exciting to see Adaptec meet .20 earnings when their year ago earnings were .51. Qtr-to-qtr earnings down 60% for a company formerly valued as a growth stock explains pretty well the current valuations. If they make .80 for FY 99 (ending 3/31/99) they would need a 25 PE to hold a $20 price. And with this earnings history, why would they merit a 25 PE?? The kicker is Symbios. If that adds even .40 to the bottom line and they make .20 per quarter off ongoing operations, we're at $1.20 and you only need a 17 PE to achieve $20. And one then hopes that there's more earnings potential both with Symbios and with new products coming along (Firewire products for example) plus maybe Symbios will be producing more than .40 even after interest charges on the debt to buy it. And do they sell the fabs, taking a hit on earnings for more cash to pay down the borrowing? Lots of questions, which is probably why the funds aren't buying, but also some opportunities. If Symbios doesn't go through, I sincerely hope they use their cash to buy back a LOT of stock at under $20. $300 million would buy back 15 million shares at $20, which would be 13% of about 115 million shares outstanding (if they could get them at an average of $18 they could buy back nearly 17 million shares or close to 15%.) This would give an instant boost to per-share earnings, even taking into account lost interest on the cash, and would generate excitement in the stock, flushing out many of the most negative shareholders glad to get out at $18 or 20. Basically, they have options and opportunities--they're still making money, they still have viable products, they're still working in a growing market, they still have a solid name well known for top technology. One has to hope that management knows what it's doing.